CVS logo

CVS Health Corporation (CVS)

$85.81

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on CVS

Market cap

$109.79B

EPS

8.6

P/E ratio

22.7

Price to sales

0.27

Dividend yield

3.1%

Beta

0.585785

Price on CVS

Previous close

$88.59

Today's open

$85.84

Day's range

$84.67 - $86.89

52 week range

$69.51 - $110.68

Profile about CVS

CEO

J. David Joyner

Employees

300000

Headquarters

Woonsocket, RI

Exchange

New York Stock Exchange

Shares outstanding

1.28B

Issue type

Common Stock

CVS industries and sectors

Healthcare

Medical Service Plans

News on CVS

CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend

CVS has the cash, the earnings momentum, and a recovering Aetna, yet shareholders have collected the same payout for 12 straight quarters. Management has other priorities first, and a planned breakup could complicate the answer.

news source

24/7 Wall Street • 7 hours ago

news preview

4 High-Yield Healthcare Stocks Retirees Should Buy for December Income

Healthcare demand holds up when the economy slows, which makes the sector a natural place for retirees to look for income heading into the new year. The quality of that income varies widely, though.

news source

24/7 Wall Street • 7 hours ago

news preview

Why CVS Health (CVS) is a Top Growth Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

news source

Zacks Investment Research • Nov 17, 2026

news preview

CVS Health Earns Global Recognition for Industry-Leading AI and Technology Innovation

CVS Health® (NYSE:CVS) is being recognized with seven Stevie® Awards for technology and responsible AI innovations that are simplifying access to care, supporting colleagues in their work, and helping communities respond to emergencies. The honors span two of the world's most competitive global award programs, the Stevie Awards for Technology Excellence and the International Business Awards® ("International Stevies").

news preview

CVS says GLP-1s save money when priced below $350 per month

The analysis looked at patients who were newly taking highly popular GLP-1 medicines — which mimic the GLP-1 hormone and reduce appetite — from Eli Lilly and Novo Nordisk, and compared them to similar patients who were not taking the drugs.

news source

New York Post • Nov 15, 2026

news preview

CVS Health: 3 Key Takeaways for Long-Term Investors

CVS Health plans to separate into two independent publicly traded companies. Management raised 2026 adjusted earnings per share guidance to at least $8.20.

news source

The Motley Fool • Nov 15, 2026

news preview

CVS Health study highlights GLP-1 benefits and the affordability challenge

Real-world analysis finds better outcomes and lower medical spending, but current prices limit the full economic value WOONSOCKET, R.I., Nov. 15, 2026 /PRNewswire/ -- CVS Health today released new research grounded in real-world data that puts numbers behind a central question facing employers and health plans as GLP-1 use grows: Do the medicines save enough elsewhere in the health care system to offset their cost?

news source

PRNewsWire • Nov 15, 2026

news preview

CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street.

Spinning off its drugstores won't quiet CVS's critics, but it could leave shareholders with a more valuable company.

news source

WSJ • Nov 13, 2026

news preview

CVS Pharmacy® launches latest collection of Caliber® Artist Series colleague-designed journals

New collection highlights creativity, community and the role of journaling in everyday wellness WOONSOCKET, R.I., Nov. 12, 2026 /PRNewswire/ -- CVS Pharmacy® (NYSE: CVS), the retail division of CVS Health®, today announced the latest collection of journals in its Caliber® Artist Series, featuring cover designs inspired by the personal experiences of health and community of four CVS Health colleagues.

news source

PRNewsWire • Nov 12, 2026

news preview

Did CVS Health Corporation Insiders Breach their Fiduciary Duties to Shareholders?

Shareholders are encouraged to contact the firm to discuss their rights and options at no cost or obligation. We would handle any matter on a contingent fee basis, whereby you would not be responsible for out-of-pocket payment of our legal fees or expenses.

news source

PRNewsWire • Nov 12, 2026

news preview

¹ Disclosures

Get started with M1

Invest in CVS Health Corporation

Open an M1 investment account to buy and sell CVS Health Corporation commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in CVS on M1